Cholecystokinin Mediates Progression and Metastasis of Pancreatic Cancer Associated with Dietary Fat
- 11 May 2014
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 59 (6) , 1180-1191
Abstract
Background Obesity and dietary fat are associated with increased risk of several malignancies including pancreatic cancer. The incidence of pancreatic cancer is increased in countries that consume diets high in fat. Aim The purpose of this study was to assess the relationship and mechanism of action between dietary fat and endogenous cholecystokinin (CCK) on pancreatic tumor growth and metastasis in an immunocompetent animal model. Methods C57BL/6 mice were placed on regular, low-fat, or high-fat diets for 8 weeks before establishment of Panc-02 orthotopic pancreatic tumors. Mice were then treated with a CCK-A receptor antagonist, devazepide, or vehicle for an additional 2.5 weeks. Pancreas tumors were weighed and metastases counted. Blood CCK levels were measured by radioimmunoassay (RIA). Tissues were examined histologically and studied for genes associated with metastasis by RT-PCR array. Effects of the CCK antagonist on Panc-02 cells invasiveness was assessed in a Matrigel invasion assay. Results Mice that received the high-fat diet had larger tumors and tenfold higher serum CCK levels by RIA compared to normal diet controls (p < 0.01). Pancreatic tumors in high-fat diet mice treated with the antagonist had fewer intravascular tumor emboli and metastases compared to controls. The reduction in tumor emboli correlated with decreased vascular endothelial growth factor-A (VEGF-A) expression in tumors (p < 6 × 10−9). In vitro invasiveness of Panc-02 cells also was reduced by CCK-A receptor antagonist treatment (p = 1.33 × 10−6). Conclusion CCK is a mediator of dietary fat-associated pancreatic cancer. CCK is also involved in the invasiveness of pancreatic tumors through a mechanism involving VEGF-A.Keywords
This publication has 51 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- CholecystokininCurrent Opinion in Endocrinology, Diabetes and Obesity, 2012
- Obesity and pancreatic cancer: Overview of epidemiologic evidence and biologic mechanismsMolecular Carcinogenesis, 2011
- Cholecystokinin Is Up-Regulated in Obese Mouse Islets and Expands β-Cell Mass by Increasing β-Cell SurvivalEndocrinology, 2010
- Obesity potentiates the growth and dissemination of pancreatic cancerSurgery, 2009
- Growth of Human Pancreatic Cancer Is Inhibited by Down-Regulation of Gastrin Gene ExpressionPancreas, 2009
- Body Mass Index and Risk, Age of Onset, and Survival in Patients With Pancreatic CancerJAMA, 2009
- Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic KrasBiochemical and Biophysical Research Communications, 2009
- Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult MiceCancer Cell, 2007
- Gastrointestinal regulation of food intakeJournal of Clinical Investigation, 2007